Karthik A. Subramanian

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Sorafenib, a clinical kinase inhibitor, attenuates Streptococcus pneumoniae pathogenesis and reduces disease progression in vivo.

Sorafenib, a clinical kinase inhibitor, attenuates Streptococcus pneumoniae pathogenesis and reduces disease progression in vivo.

Journal: mBio

Published: June 16, 2026

Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection.

Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection.

Journal: iScience

Published: February 02, 2024

Editorial: Deceiving the host: mechanisms of immune evasion and survival by pneumococcal bacteria.

Editorial: Deceiving the host: mechanisms of immune evasion and survival by pneumococcal bacteria.

Journal: Frontiers in cellular and infection microbiology

Published: May 30, 2023

Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates.

Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates.

Journal: Frontiers in cellular and infection microbiology

Published: December 15, 2021

Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease.

Mannose receptor-derived peptides neutralize pore-forming toxins and reduce inflammation and development of pneumococcal disease.

Journal: EMBO molecular medicine

Published: May 07, 2020

Genomic Characterization of the Emerging Pathogen Streptococcus pseudopneumoniae.

Genomic Characterization of the Emerging Pathogen Streptococcus pseudopneumoniae.

Journal: mBio

Published: June 27, 2019

Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen.

Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen.

Journal: Cellular microbiology

Published: March 14, 2019

Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.

Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival.

Journal: Nature microbiology

Published: February 07, 2018

Vitamin D Promotes Pneumococcal Killing and Modulates Inflammatory Responses in Primary Human Neutrophils.

Vitamin D Promotes Pneumococcal Killing and Modulates Inflammatory Responses in Primary Human Neutrophils.

Journal: Journal of innate immunity

Published: October 12, 2016

Adsorptive removal of dye using biochar derived from residual algae after in-situ transesterification: Alternate use of waste of biodiesel industry.

Adsorptive removal of dye using biochar derived from residual algae after in-situ transesterification: Alternate use of waste of biodiesel industry.

Journal: Journal of environmental management

Published: April 22, 2016

Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity.

Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity.

Journal: PloS one

Published: March 11, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026